Eli Lilly's diabetes drug Mounjaro back in stock amid heightened obesity interest

After an FDA approval last year, Eli Lilly’s diabetes drug Mounjaro has been on fire right out of the gate. Now, the Indianapolis pharma giant says it's resolved a months-long shortage.